Web-based intervention for sexual health in young female cancer survivors
Assessing the Impact of a Web-based Educational Program on the Sexual Health Outcomes of Young Adult Female Cancer Survivors ~ A Pilot Trial
This study tests whether a web-based program can help young female cancer survivors improve their sexual health and well-being after treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 18 Years to 45 Years |
| Sex | Female |
| Sponsor | University of Chicago Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06868121 on ClinicalTrials.gov |
What this trial studies
This pilot trial evaluates the impact of the web-based intervention OMGYES.com on sexual dysfunction among young adult female-bodied cancer survivors aged 18 to 40. Participants will complete online modules at home and attend clinic visits every five weeks to fill out questionnaires. The study aims to assess the feasibility, acceptability, and appropriateness of the intervention by comparing outcomes between those receiving the intervention immediately and those who do not. The trial focuses on individuals who have completed cancer treatment and are in remission.
Who should consider this trial
Good fit: Ideal candidates are young adult female-bodied individuals aged 18 to 40 who have been diagnosed with cancer and are experiencing sexual dysfunction.
Not a fit: Patients currently receiving other investigational agents or those with high infection risks that prevent participation may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve sexual health and quality of life for young female cancer survivors experiencing sexual dysfunction.
How similar studies have performed: While this specific approach is novel, other studies have explored web-based interventions for sexual health, showing promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 to 45 years * Diagnosis of cancer between the ages of 15 and 45 * Female genitalia, regardless of gender * Diagnosed with sexual dysfunction * Complete Remission and at least two months from a major treatment * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial * Ability to participate in study modules and to respond to surveys * Ability to understand and the willingness to sign a written informed consent document Exclusion Criteria: * Patients receiving other investigational agents * Patients expected to be neutropenic or have a significantly high infection risk that would exclude them from vaginal penetration * Patients who are unable complete the study intervention or surveys
Where this trial is running
Chicago, Illinois
- University of Chicago Hospital — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Adam DuVall, MD — University of Chicago
- Study coordinator: Cassandra Kuissi, BS
- Email: cassandra.kuissi@bsd.uchicago.edu
- Phone: 7737021220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.